A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders

BACKGROUND: This study examined the efficacy and safety of N-acetylcysteine (NAC) augmentation for treating irritability in children and adolescents with autism spectrum disorders (ASD). METHOD: Forty children and adolescents met diagnostic criteria for ASD according to DSM-IV. They were randomly al...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanizadeh, Ahmad, Moghimi-Sarani, Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737121/
https://www.ncbi.nlm.nih.gov/pubmed/23886027
http://dx.doi.org/10.1186/1471-244X-13-196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737121/
https://www.ncbi.nlm.nih.gov/pubmed/23886027
http://dx.doi.org/10.1186/1471-244X-13-196

Ejemplares similares